CHF-6523

• Description :

  CHF-6523 is an orally active PI3Kδ inhibitor that can be used in research related to chronic obstructive pulmonary disease (COPD) [1].

• UNSPSC :

  12352211

• Target :

  PI3K

• Type :

  Reference compound

• Related Pathways :

  PI3K/Akt/mTOR

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/chf-6523.html

• Smiles :

  CN(CC1)CCN1CC2=CC(C(C3=CC=CC=C34)=C([C@H](C)N5C(N=CN=C6N)=C6C(C7=CN=CC(O)=C7)=N5)OC4=O)=CC=C2

• Molecular Formula :

  C33H32N8O3

• Molecular Weight :

  588.66

• References & Citations :

  [1]First-Time Drug Disclosures- 2024 EFMC-ISMC and ACS Fall

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 1

• Isoform :

  PI3Kδ

• CAS Number :

  [2500579-21-3]